Lovish Garg: Restoring Venous Flow Through Catheter-Directed Thrombus Removal
Lovish Garg, Endovascular and Interventional Radiologist at SPS Hospitals, shared a post on LinkedIn:
“Venous Thrombolysis and Thrombectomy: Restoring Blood Flow Through Minimally Invasive Treatment.
Deep Vein Thrombosis (DVT) is a serious vascular condition caused by the formation of blood clots within deep veins, most commonly in the legs.
If left untreated, these clots can lead to long-term vein damage, chronic swelling, pain, and potentially life-threatening complications such as Pulmonary Embolism.
Advancements in Interventional Radiology have transformed the management of venous thrombosis through minimally invasive, image-guided procedures such as Venous Thrombolysis and Thrombectomy.
Understanding the Treatment Options:
Venous Thrombolysis
Delivers clot-dissolving medication directly into the thrombus, allowing targeted treatment while minimizing systemic exposure.
Mechanical Thrombectomy
Uses specialized devices to remove the clot and rapidly restore blood circulation.
Pharmacomechanical Thrombectomy
Combines clot-dissolving therapy with mechanical clot extraction for selected patients requiring advanced intervention.
Key Benefits:
- Rapid restoration of blood flow
- Reduction in pain, swelling, and venous congestion
- Preservation of long-term vein function
- Lower risk of Post-Thrombotic Syndrome (PTS)
- Minimally invasive approach with image-guided precision
- Shorter recovery time and hospital stay
Who May Benefit?
- Patients with Deep Vein Thrombosis (DVT)
- Individuals with extensive venous thrombosis
- Patients experiencing significant clot-related symptoms
- Those at risk of long-term venous complications
Early diagnosis and timely intervention remain critical in improving patient outcomes and preventing avoidable complications.
As Interventional Radiologists, our goal is not only to remove the clot but also to preserve vein health, improve quality of life, and reduce the long-term burden of venous disease through evidence-based, minimally invasive care.”
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 20:33Jennifer Weinstein: Happy to Share Our New Work on the Patient Experience in VWD at the NBDF Conference
-
Sep 3, 2026, 20:31Guillaume Courbon: New Publication on Erythroid-Produced FGF23 and Its Role in Anemia
-
Sep 3, 2026, 20:30Phuong Khanh Morrow: FDA Approval Marks an Important Step Forward for the PV Community
-
Sep 3, 2026, 20:29Sarah Robins: Happy to Share This Portrait Film I Voiced for the NNHHF
-
Sep 3, 2026, 20:27Mireille Muller: Europe Needs More Plasma Donors
-
Sep 3, 2026, 17:54Tareq Abadl: Extravascular Hemolysis The High-Yield Guide
-
Sep 3, 2026, 17:48Isabel Sá: Starting a New Chapter as a Clinical Scientist in Molecular Genetics and Haematology
-
Sep 3, 2026, 17:40Chiwoo Oh: AS01B Adjuvant and Long-Term Immune Reprogramming After Shingrix Vaccination
-
Sep 3, 2026, 17:35Key Developments in Transfusion Medicine and Biotherapies in 2025 – AABB